The Japanese big pharma adds the new gene therapy candidate to its pipeline in a US$50 million deal in equity and upfront payments. AviadoBio was founded in London in 2019 based on research carried ...
Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer vaccine targets. Danish techbio company Evaxion Biotech has published results ...